A serum creatinine level to assess the renal function.
Check the PSA, if the patient’s life expectancy is above 10 years, prostate cancer is suspected during physical examination, and treatment plan includes the use of 5 alpha reductase inhibitor therapy. A urologist referral for a prostate ultrasound or a magnetic resonance imaging (MRI) if indicated (Buttaro, et al, 2013).
Diagnosis
Benign prostatic hyperplasia is the benign enlargement of the prostate gland common in male age 50 and above, black males are at a higher risk compared to their white counterparts. Although, advancing in age is considered a contributing factor for BPH, androgen secretion, its receptors function, the presence of both testes, and the formation of the Dihydrotestosterone (DHT), and its maintenance level contributes to prostate enlargement, therefore monitoring the above is recommended. In addition, common characteristic signs and symptoms of BPH are urinary frequency, urgency, nocturia, urge or overflow incontinence, difficulty in starting or stopping urine stream, postvoid dribbling and reduction in the force of the stream (Buttaro, et al, 2013). However, the patient in the case scenario has experienced the urinary frequency for several months, and have increased over the past week. Considering, the urinary symptom presented, its progression, patient’s age, and the ethnic background BPH is my confirmatory